The share of public procurement in the overall structure of drug sales in Russian pharmaceutical market has reached 34.4% in the first half of 2019, which became a historical record figure for the cou...
A number of new innovative drugs were added to the list of free medicines including those for the treatment of tuberculosis. This was announced by the Kazakhstan’s Minister of Health Elzhan Birtanov at a public meeting.
A relevant draft order on additional preferences for manufacturers is being prepared for state registration in the Ministry of Justice, announced the press service of the Russian Ministry of Industry and Trade.
Pharmstandard turned out to be the only pharmaceutical company that made a bid for supplying rilpivirine + tenofovir + emtricitabine, a three-component antiretroviral medication included in the list of vital and essential drugs.
Nacimbio JSC, a pharmaceutical subsidiary of Rostec Corporation, signed four new contracts with the Russian Ministry of Health for 2018 supplies of blood-derived products under the Seven Nosologies program.
The Ministry of Health of the Russian Federation announced the results of the tender for supply of dasabuvir/ombitasvir/paritaprevir/ritonavir, a new drug for hepatitis C. As it was expected, the declared winner was R-Pharm.